TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

73.10$ +3.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow WGS
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +83.1% +85.8% +172.0% -39.6% -38.7% +14.9%
– +2,093.2% +82.5% -80.9% -100.8% – +252.0%
– +2,211.2% -79.6% +435.5% – – –
– – -41.7% +347.3% -205.8% – –
– +106.9% -35.0% -31.1% -60.1% -3.9% +246.3%
– +106.9% -35.0% +579.9% -69.1% -31.1% +104.2%
– – – – – – –
– – -214.8% -75.6% – -107.5% +13.6%
– -12.8% +282.6% -60.0% -5.6% -76.3% +8.7%
– -96.5% +7,044.9% -193.2% – – –
– – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?